We serve Chemical Name:methyl 6-chlorohexanoate CAS:14273-89-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:methyl 6-chlorohexanoate
CAS.NO:14273-89-3
Synonyms:6-chloro-1-hexanoic acid methyl ester;Hexanoic acid,6-chloro-,methyl ester;6-Chlorhexansaeure-methylester;6-chloro-hexanoic acid methyl ester
Molecular Formula:C7H13ClO2
Molecular Weight:164.63000
HS Code:2915900090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:191.1ºC at 760mmHg
Density:1.035g/cm3
Index of Refraction:1.43
PSA:26.30000
Exact Mass:164.06000
LogP:1.95860
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 6-chloro-1-hexanoic acid methyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-chloro-hexanoic acid methyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-Chlorhexansaeure-methylester Use and application,6-chloro-1-hexanoic acid methyl ester technical grade,usp/ep/jp grade.
Related News: Two sources familiar with the situation told Reuters that the agency had cleared about 10 million doses. methyl 6-chlorohexanoate manufacturer AbbVie and Johnson & Johnson already boast three FDA-approved regimens for Imbruvica in newly diagnosed chronic lymphocytic leukemia (CLL). Now, the pair aims to add another to the drug’s label, one that could shorten the time patients need to stay on treatment. methyl 6-chlorohexanoate supplier AbbVie and Johnson & Johnson already boast three FDA-approved regimens for Imbruvica in newly diagnosed chronic lymphocytic leukemia (CLL). Now, the pair aims to add another to the drug’s label, one that could shorten the time patients need to stay on treatment. methyl 6-chlorohexanoate vendor In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired. methyl 6-chlorohexanoate factory In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired.
